(Q92458780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

Borrelia burgdorferi

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Maria Esteve-gassent

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Wisam Salim Hassan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Paula R Giaretta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Morgane Ollivault-Shiflett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

publication date

3 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

5596-5606

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

Lyme disease: A rigorous review of diagnostic criteria and treatment

29 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

The biological and social phenomenon of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Reciprocal expression of ospA and ospC in single cells of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

An Octavalent Lyme Disease Vaccine Induces Antibodies That Recognize All Incorporated ospC Type-Specific Sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Developing vaccines in the era of genomics: a decade of reverse vaccinology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Reverse vaccinology: developing vaccines in the era of genomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Evolution of the core and pan-genome of Streptococcus: positive selection, recombination, and genome composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Immunization with a Borrelia burgdorferi BB0172-derived peptide protects mice against lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

BB0172, a Borrelia burgdorferi outer membrane protein that binds integrin α3β1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Protein carriers of conjugate vaccines: characteristics, development, and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Vaccines based on the cell surface carbohydrates of pathogenic bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Role of the BBA64 locus of Borrelia burgdorferi in early stages of infectivity in a murine model of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

sodAis essential for virulence ofBorrelia burgdorferiin the murine model of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Inactivation of the fibronectin-binding adhesin genebbk32significantly attenuates the infectivity potential ofBorrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Elimination of lyme disease spirochetes from ticks feeding on domestic ruminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Meningococcal surrogates of protection--serum bactericidal antibody activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

MenACWY-TT vaccine for active immunization against invasive meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

History of meningococcal vaccines and their serological correlates of protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Perspective of Peptide Vaccine Composed of Epitope Peptide, CpG-DNA, and Liposome Complex Without Carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Recent advances in peptide-based subunit nanovaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Haemophilus influenzae type b conjugate vaccines: a review of efficacy data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

The HC fragment of tetanus toxin forms stable, concentration-dependent dimers via an intermolecular disulphide bond.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Role of epitope density in the induction of immunity and tolerance with thymus-independent antigens. II. Studies with 2,4-dinitrophenyl conjugatesin vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

The influence of antigen organization on B cell responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Activating B Cell Signaling with Defined Multivalent Ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Effects of hapten density on the induced antibody repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Cultivation of Borrelia burgdorferi in dialysis membrane chambers in rat peritonea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Virulence of the Lyme disease spirochete before and after the tick bloodmeal: a quantitative assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

The Lyme disease agent exploits a tick protein to infect the mammalian host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.07.092

10.1016/J.VACCINE.2019.07.092

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31387750%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference